One of the most common genetic alterations in sarcomas with complex karyotypes is tumor protein 53 (TP53) inactivation, either via somatic mutation, deletion, or alterations in TP53 pathway genes such as CDKN2A and MDM2 [5,7]. The gene discussed is TP53; the disease is sarcoma.